• MMP-2 Responsive Liposomes for Sequential Immunotherapy in B

  2026-06-08

  This study presents an intelligent, dual-targeting liposomal system that sequentially delivers a PD-1/PD-L1 blockade peptide and an IDO inhibitor to remodel the immunosuppressive microenvironment in breast cancer. The approach demonstrates enhanced specificity, efficacy, and safety compared to conventional immunotherapy regimens, offering a promising direction for advanced nanomedicine-driven cancer immunotherapy.

• Honokiol Triggers Paraptosis in APL via mTOR and MAPK Pathwa

  2026-06-07

  This study demonstrates that honokiol induces paraptosis-like cell death in acute promyelocytic leukemia (APL) cells through activation of mTOR and MAPK signaling, offering a caspase-independent therapeutic avenue. These findings broaden mechanistic understanding of nonapoptotic cell death, with implications for overcoming resistance in APL treatment.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Precision Tools for Quantit

  2026-06-06

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP), a Cy5-labeled mRNA, revolutionizes gene delivery research with dual fluorescence and immune-evasive chemistry. This article uniquely integrates practical assay design with new insights from β cell-targeted mRNA delivery, offering actionable guidance for advanced transfection studies.

• Sodium Ascorbate: Benchmarks and Mechanism in Oncology Resea

  2026-06-05

  Sodium Ascorbate, a mineral salt of ascorbic acid, shows enhanced bioavailability and induces intracellular ROS, leading to selective necrotic death of tumor cells. Its validated use in glioblastoma and prostate cancer models underscores its reliability for mechanistic oncology workflows.

• AP20187 (SKU B1274): Reliable CID for Conditional Gene Thera

  2026-06-05

  This article delivers a scenario-driven, evidence-based exploration of AP20187 (SKU B1274) as a chemical inducer of dimerization (CID) for conditional gene therapy and regulated cell assays. We address real-world lab challenges, protocol optimization, and vendor selection, highlighting why AP20187 is a trusted reagent for reproducibility and sensitivity.

• Hoechst 33342: Mechanisms, Applications, and Workflow Best P

  2026-06-04

  Hoechst 33342 is a bis-benzimidazole fluorescent dye that enables precise nuclear visualization and cell cycle analysis. Its DNA minor groove binding and blue fluorescence emission underpin robust use in live-cell imaging and apoptosis assays. This article clarifies verified mechanisms, protocol benchmarks, and common pitfalls for optimal integration in research workflows.

• 3-Deazaadenosine: S-Adenosylhomocysteine Hydrolase Inhibitor

  2026-06-04

  3-Deazaadenosine empowers researchers to interrogate methylation-dependent pathways and viral mechanisms with precision. This guide distills best practices, innovative workflows, and troubleshooting strategies—bridging epigenetic regulation with translational antiviral research using APExBIO’s gold-standard reagent.

• Reliable Cell-Based Assays with FLAG tag Peptide (DYKDDDDK)

  2026-06-03

  This article provides scenario-driven, evidence-based guidance for biomedical researchers and lab technicians using FLAG tag Peptide (DYKDDDDK) (SKU A6002) in cell viability, proliferation, and cytotoxicity assays. By addressing real experimental challenges and benchmarking key parameters, it demonstrates how the APExBIO formulation supports reproducible, sensitive, and efficient workflows.

• Arctigenin (SKU N2399): Robust Solutions for Cell Assays

  2026-06-03

  This article guides biomedical researchers and lab technicians through scenario-driven strategies for using Arctigenin (SKU N2399) to achieve reproducible, high-sensitivity results in cell viability, proliferation, and cytotoxicity assays. Grounded in peer-reviewed evidence and APExBIO’s product dossier, it addresses common laboratory pitfalls, protocol optimization, and vendor selection, positioning Arctigenin as a reliable, data-backed solution for advanced experimental workflows.

• Decoding Mitochondrial Potential: TMRE Assays for NECSO Rese

  2026-06-02

  Explore how the TMRE mitochondrial membrane potential assay kit enables translational researchers to dissect sodium-induced mitochondrial dysfunction, with mechanistic insights from NECSO pathway studies. This article connects the latest mechanistic evidence to assay strategy, benchmarking TMRE protocols and illuminating translational opportunities in cell death and mitochondrial function analysis.

• Biotin-16-UTP: Technical Guidance for RNA Labeling Workflows

  2026-06-02

  Biotin-16-UTP addresses the need for robust, specific RNA labeling in complex molecular biology workflows, such as RNA detection, purification, and interaction studies. Its use is recommended for in vitro transcription-based RNA labeling but not for diagnostic or clinical applications.

• Methotrexate as a Folate Antagonist: Advanced Research Workf

  2026-06-01

  Methotrexate’s dual action as a folate antagonist and immunosuppressive agent enables precise modeling of apoptotic and anti-inflammatory pathways. Leveraging innovations in assay design and permeability screening, researchers can achieve higher reproducibility and translational relevance across immunology, oncology, and pharmacokinetics studies.

• Ambroxol Modulation of Nav1.8, TRPV1, and TRPA1 in Neuropath

  2026-06-01

  This study delineates how ambroxol modulates human Nav1.8 sodium channels and the irritant receptors TRPV1 and TRPA1, key targets in the topical treatment of neuropathic pain. The findings clarify species-specificity, mechanisms of channel inhibition, and ambroxol’s interaction with capsaicin-induced TRPV1 activity, informing future research on targeted analgesic strategies.

• Indomethacin Sodium Trihydrate: COX Inhibitor for Inflammati

  2026-05-31

  Indomethacin Sodium Trihydrate is a non-selective COX inhibitor used in inflammation and pain signaling pathway research. Rigorous evidence supports its efficacy in prostaglandin synthesis inhibition and remyelination assays, with well-defined in vitro and in vivo protocols.

• GS-441524 Prodrug: Advanced Pharmacokinetics and Assay Impli

  2026-05-30

  Explore the multifaceted pharmacokinetics and analytical strategies for GS-441524, a leading nucleoside analog in antiviral research. This article uniquely deciphers conversion pathways and practical assay parameters, offering actionable insights for GS-441524 prodrug studies.

543 records 15/37 page Previous Next First page 上5页 1112131415 下5页 Last page